Insight Molecular Diagnostics (IMDX) Return on Invested Capital (2020 - 2026)
Insight Molecular Diagnostics (IMDX) posted Return on Invested Capital of 0.07% for Q3 2024, up 21.97% sequentially from 0.09% in Q2 2024.
Insight Molecular Diagnostics (IMDX) Return on Invested Capital (2020 - 2026) Analysis & Trends
Insight Molecular Diagnostics has reported Return on Invested Capital for 3 years, with the latest figure at 0.07% in Q3 2024.
- Quarterly Return on Invested Capital changed N/A year-over-year to 0.07% in Q3 2024, while the trailing twelve-month figure through Sep 2024 was 0.07% (changed N/A YoY) and the FY2022 annual result came in at 0.22%, up 1.0% from the prior year.
- Return on Invested Capital improved to 0.07% in Q3 2024 per IMDX's latest filing, from 0.09% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.02% in Q3 2021 and troughed at 0.11% in Q1 2024.
- A 3-year average of 0.05% and a median of 0.04% in 2021 frame the typical range for Return on Invested Capital.
- The widest YoY moves for Return on Invested Capital: up 1 bps in 2021, down 1 bps in 2021.
- Over 3 years, Return on Invested Capital stood at 0.05% in 2020, then grew by 24 bps to 0.04% in 2021, then sank by 109 bps to 0.07% in 2024.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.07%, 0.09%, and 0.11% for Q3 2024, Q2 2024, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 0.01% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 0.02% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -0.01% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 0.02% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 0.00% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 0.01% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 0.04% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 0.02% |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | -0.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18% |
| Mar 31, 2026 | -0.16% |
| Dec 31, 2025 | -0.14% |
| Sep 30, 2025 | -0.17% |
| Jun 30, 2025 | -0.20% |
| Mar 31, 2025 | -0.22% |
| Dec 31, 2024 | -0.18% |
| Sep 30, 2024 | -0.13% |
| Jun 30, 2024 | -0.13% |
| Mar 31, 2024 | -0.15% |
| Dec 31, 2021 | -0.04% |
| Sep 30, 2021 | -0.02% |
| Jun 30, 2021 | -0.02% |
| Mar 31, 2021 | -0.03% |
| Dec 31, 2020 | -0.04% |